See how to make money instead of spending it on Black Friday with this offer

Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction…

It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it.

And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.

Get Nomi’s latest stock market prediction for $19

INCY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.50%

Insider Buying (Last 12 Months): $153,065,544.39

Insider Selling (Last 12 Months): $6,047,393.90

Incyte Insider Trading History Chart

Incyte Share Price & Price History

^$78.26

▲ +0.5 (0.64%)

As of 11/25/2022 01:00 AM ET

Days: 30 | 90 | 365

See how to make money instead of spending it on Black Friday with this offer

From Legacy Research | Ad

Get Nomi’s latest stock market prediction for $19

Incyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/22/2022	Thomas Tray	Insider	Sell	1,564	$83.13	$130,015.32	17,702
7/7/2022	Vijay K. Iyengar	EVP	Sell	5,787	$79.38	$459,372.06	40,313
4/8/2022	Barry P Flannelly	EVP	Sell	43,993	$83.49	$3,672,975.57	65,163
3/10/2022	Bros. Advisors Lp Baker	Director	Buy	218,563	$73.13	$15,983,512.19
3/8/2022	Bros. Advisors Lp Baker	Director	Buy	100,000	$70.67	$7,067,000.00
2/22/2022	Bros. Advisors Lp Baker	Director	Buy	99,800	$68.07	$6,793,386.00
2/17/2022	Bros. Advisors Lp Baker	Director	Buy	292,972	$67.74	$19,845,923.28
1/31/2022	Jonathan Elliott Dickinson	EVP	Sell	7,375	$74.19	$547,151.25
1/7/2022	Paula J. Swain	EVP	Sell	10,870	$73.31	$796,879.70
12/23/2021	Wendy L. Dixon	Director	Sell	20,000	$22.05	$441,000.00
12/17/2021	Bros. Advisors Lp Baker	Director	Buy	1,075,872	$72.80	$78,323,481.60
12/15/2021	Bros. Advisors Lp Baker	Director	Buy	350,332	$71.51	$25,052,241.32
10/1/2021	Dashyant Dhanak	EVP	Sell	389	$68.67	$26,712.63
9/1/2021	Dashyant Dhanak	EVP	Sell	388	$76.71	$29,763.48
7/29/2021	Vijay K. Iyengar	EVP	Sell	4,911	$78.29	$384,482.19
6/29/2021	Wenquing Yao	EVP	Sell	27,194	$85.37	$2,321,551.78
4/1/2021	Dashyant Dhanak	EVP	Sell	396	$81.57	$32,301.72
3/29/2021	Michael James Morrissey	EVP	Sell	20,000	$81.08	$1,621,600.00
2/23/2021	Herve Hoppenot	President	Buy	12,925	$77.37	$1,000,007.25
1/25/2021	Wenquing Yao	EVP	Sell	21,545	$100.00	$2,154,500.00	145,343
10/9/2020	Maria E. Pasquale	EVP	Sell	1,423	$95.00	$135,185.00	29,754
9/10/2020	Maria E. Pasquale	EVP	Sell	2,193	$90.83	$199,190.19	30,397
9/8/2020	Dashyant Dhanak	EVP	Sell	961	$88.94	$85,471.34	28,971
7/16/2020	Steven H. Stein	EVP	Sell	766	$103.83	$79,533.78	96,234
7/8/2020	Steven H. Stein	EVP	Sell	610	$108.56	$66,221.60	104,131
7/7/2020	Herve Hoppenot	CEO	Sell	89,771	$110.00	$9,874,810.00	279,662
7/6/2020	Wenquing Yao	EVP	Sell	16,553	$107.32	$1,776,467.96	158,849
6/26/2020	Herve Hoppenot	CEO	Sell	124,148	$102.91	$12,776,070.68	245,250
6/23/2020	Paul Trower	Insider	Sell	6,943	$110.00	$763,730.00	28,677
6/22/2020	Jonathan Elliott Dickinson	EVP	Sell	9,000	$105.31	$947,790.00	36,461
6/19/2020	Maria E. Pasquale	EVP	Sell	1,423	$100.00	$142,300.00	25,084
5/28/2020	Bros. Advisors Lp Baker	Director	Buy	2	$102.55	$205.10
5/6/2020	Dashyant Dhanak	EVP	Sell	961	$96.84	$93,063.24	20,948
4/17/2020	Paul Trower	Insider	Sell	1,143	$100.00	$114,300.00	22,467
4/16/2020	Maria E. Pasquale	EVP	Sell	9,488	$95.00	$901,360.00	32,837
4/14/2020	Maria E. Pasquale	EVP	Sell	17,827	$90.00	$1,604,430.00	23,864
4/6/2020	Maria E. Pasquale	EVP	Sell	1,842	$85.00	$156,570.00	23,831
3/31/2020	Paula J. Swain	EVP	Sell	2,329	$71.44	$166,383.76	50,132
2/19/2020	Paula J. Swain	EVP	Sell	2,500	$80.00	$200,000.00	50,993
1/15/2020	Paula J. Swain	EVP	Sell	2,500	$81.12	$202,800.00	44,112
12/16/2019	Paula J. Swain	EVP	Sell	2,500	$91.61	$229,025.00	44,112
12/2/2019	Wenquing Yao	EVP	Sell	16,835	$95.00	$1,599,325.00	98,473
11/29/2019	Wenquing Yao	EVP	Sell	3,165	$95.00	$300,675.00	98,473

THE BEST BLACK FRIDAY DEAL YET

From Legacy Research | Ad

This Black Friday, you can save 95% off of a 1-year membership to Brad Thomas’s Intelligent Income Investor.

This service is geared toward helping you collect the safest dividend income in the market.

It all starts with Brad’s “SWAN” portfolio, of the 10 best companies to own through any market.

Click here now to claim this 95% discount.

SEC Filings (Institutional Ownership Changes) for Incyte (NASDAQ:INCY)

94.74% of Incyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Incyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/23/2022	Toroso Investments LLC	12,455	$0.83M	0.0%	+12.3%	0.006%
11/22/2022	Teachers Retirement System of The State of Kentucky	16,988	$1.13M	0.0%	N/A	0.008%
11/21/2022	California State Teachers Retirement System	316,277	$21.08M	0.0%	-0.3%	0.142%
11/18/2022	National Pension Service	312,123	$20.79M	0.0%	-2.3%	0.140%
11/17/2022	CENTRAL TRUST Co	1,202	$80K	0.0%	N/A	0.001%
11/17/2022	M&T Bank Corp	13,943	$0.93M	0.0%	+19.7%	0.006%
11/16/2022	Retirement Systems of Alabama	61,319	$4.09M	0.0%	-62.7%	0.028%
11/16/2022	Captrust Financial Advisors	8,188	$0.55M	0.0%	+80.3%	0.004%
11/16/2022	Kentucky Retirement Systems Insurance Trust Fund	6,616	$0.44M	0.0%	+2.8%	0.003%
11/16/2022	Kentucky Retirement Systems	14,452	$0.96M	0.0%	+3.4%	0.006%
11/16/2022	AIMZ Investment Advisors LLC	57,182	$3.81M	1.9%	+0.9%	0.026%
11/16/2022	Balyasny Asset Management LLC	202,470	$13.49M	0.0%	+1,775.2%	0.091%
11/16/2022	Baird Financial Group Inc.	231,321	$15.42M	0.0%	-5.0%	0.104%
11/16/2022	Meiji Yasuda Asset Management Co Ltd.	19,973	$1.33M	0.1%	-1.4%	0.009%
11/16/2022	MidWestOne Financial Group Inc.	13,826	$0.92M	0.2%	-17.3%	0.006%
11/16/2022	BNP Paribas Arbitrage SNC	340,862	$22.72M	0.0%	+20.1%	0.153%
11/16/2022	Ashford Capital Management Inc.	432,938	$28.85M	4.4%	-4.2%	0.195%
11/15/2022	Neuberger Berman Group LLC	3,210	$0.21M	0.0%	N/A	0.001%
11/15/2022	Alliancebernstein L.P.	238,705	$15.91M	0.0%	-43.3%	0.107%
11/15/2022	State Street Corp	9,552,953	$636.61M	0.0%	+1.1%	4.294%
11/15/2022	Public Employees Retirement System of Ohio	94,794	$6.32M	0.0%	+2.0%	0.043%
11/15/2022	Jacobs Levy Equity Management Inc.	1,156,285	$77.06M	0.6%	+2.0%	0.520%
11/15/2022	Summit Global Investments	246,470	$16.43M	1.5%	+3.6%	0.111%
11/15/2022	Twinbeech Capital LP	10,801	$0.72M	0.0%	N/A	0.005%
11/15/2022	Two Sigma Advisers LP	740,300	$49.33M	0.1%	-11.6%	0.333%
11/15/2022	Two Sigma Investments LP	60,498	$4.03M	0.0%	-84.1%	0.027%
11/15/2022	Teza Capital Management LLC	14,637	$0.98M	0.2%	N/A	0.007%
11/15/2022	Trexquant Investment LP	80,934	$5.39M	0.2%	N/A	0.036%
11/15/2022	UBS Asset Management Americas Inc.	1,932,324	$128.77M	0.1%	-11.1%	0.869%
11/15/2022	Utah Retirement Systems	32,929	$2.19M	0.0%	+0.6%	0.015%
11/15/2022	Vanguard Group Inc.	21,228,061	$1.41B	0.0%	+1.1%	9.542%
11/15/2022	Partners Capital Investment Group LLP	151,446	$10.09M	0.6%	-31.0%	0.068%
11/15/2022	Pathstone Family Office LLC	3,071	$0.21M	0.0%	N/A	0.001%
11/15/2022	PAX Financial Group LLC	15,488	$1.03M	0.3%	+3.9%	0.007%
11/15/2022	Prelude Capital Management LLC	8,617	$0.57M	0.0%	N/A	0.004%
11/15/2022	Price T Rowe Associates Inc. MD	2,306,872	$153.73M	0.0%	-32.3%	1.037%
11/15/2022	Putnam Investments LLC	45,025	$3M	0.0%	-4.1%	0.020%
11/15/2022	Prosight Management LP	40,450	$2.70M	1.4%	N/A	0.018%
11/15/2022	Quantamental Technologies LLC	6,851	$0.46M	0.2%	N/A	0.003%
11/15/2022	Marshall Wace LLP	47,800	$3.19M	0.0%	N/A	0.021%
11/15/2022	Martingale Asset Management L P	42,582	$2.84M	0.1%	+53.2%	0.019%
11/15/2022	Echo Street Capital Management LLC	13,298	$0.89M	0.0%	N/A	0.006%
11/15/2022	Ensign Peak Advisors Inc	83,944	$5.59M	0.0%	-6.9%	0.038%
11/15/2022	Federated Hermes Inc.	4,231	$0.28M	0.0%	-80.4%	0.002%
11/15/2022	Fifth Lane Capital LP	10,067	$0.67M	0.3%	N/A	0.005%
11/15/2022	First Trust Advisors LP	987,474	$65.81M	0.1%	-69.1%	0.444%
11/15/2022	Frontier Capital Management Co. LLC	75,781	$5.05M	0.1%	-0.5%	0.034%
11/15/2022	Bank of New York Mellon Corp	1,458,825	$97.22M	0.0%	-7.5%	0.656%
11/15/2022	Bellevue Group AG	2,744,277	$182.88M	2.6%	-1.0%	1.233%
11/15/2022	BlackRock Inc.	19,644,663	$1.31B	0.0%	+3.1%	8.830%
11/15/2022	Caisse DE Depot ET Placement DU Quebec	307,179	$20.47M	0.1%	+101.7%	0.138%
11/15/2022	Capital Fund Management S.A.	16,872	$1.12M	0.0%	N/A	0.008%
11/15/2022	Capital International Ltd. CA	28,522	$1.90M	0.1%	+10.8%	0.013%
11/15/2022	Caxton Associates LP	10,265	$0.68M	0.1%	N/A	0.005%
11/15/2022	CI Investments Inc.	507	$34K	0.0%	+76.7%	0.000%
11/15/2022	Commonwealth Equity Services LLC	17,020	$1.13M	0.0%	-70.5%	0.008%
11/14/2022	Horizon Investments LLC	3,911	$0.26M	0.0%	+18.8%	0.002%
11/14/2022	United Capital Financial Advisers LLC	9,501	$0.63M	0.0%	-1.4%	0.004%
11/14/2022	AlphaCrest Capital Management LLC	35,900	$2.39M	0.1%	+10.2%	0.016%
11/14/2022	Macquarie Group Ltd.	134,536	$8.97M	0.0%	-0.4%	0.060%
11/14/2022	Gabelli Funds LLC	15,700	$1.05M	0.0%	-1.9%	0.007%
11/14/2022	Armistice Capital LLC	2,366,000	$157.67M	2.7%	+18.3%	1.063%
11/14/2022	Royal Bank of Canada	9,206,851	$613.54M	0.2%	+0.6%	4.138%
11/14/2022	Eaton Vance Management	184,963	$12.33M	0.0%	+0.2%	0.083%
11/14/2022	Tudor Investment Corp Et Al	25,924	$1.73M	0.0%	+777.6%	0.012%
11/14/2022	Virtus ETF Advisers LLC	11,756	$0.78M	0.3%	+235.3%	0.005%
11/14/2022	Cubist Systematic Strategies LLC	156,621	$10.44M	0.1%	+48.8%	0.070%
11/14/2022	Guggenheim Capital LLC	78,538	$5.23M	0.0%	-15.3%	0.035%
11/14/2022	Cim Investment Management Inc.	7,112	$0.47M	0.2%	N/A	0.003%
11/14/2022	Wolverine Trading LLC	3,208	$0.21M	0.0%	-54.8%	0.001%
11/14/2022	Renaissance Technologies LLC	4,847,233	$323.02M	0.5%	-5.7%	2.179%
11/14/2022	Verition Fund Management LLC	4,274	$0.29M	0.0%	-33.5%	0.002%
11/14/2022	Lazard Asset Management LLC	28,827	$1.92M	0.0%	+11.6%	0.013%
11/14/2022	Nuveen Asset Management LLC	523,110	$34.86M	0.0%	-1.4%	0.235%
11/14/2022	Canada Pension Plan Investment Board	440,492	$29.35M	0.0%	+10.1%	0.198%
11/14/2022	Parkwood LLC	19,986	$1.33M	0.2%	+24.1%	0.009%
11/14/2022	AXA S.A.	122,767	$8.18M	0.0%	-5.3%	0.055%
11/14/2022	Vantage Consulting Group Inc	3,561	$0.24M	0.1%	+4.4%	0.002%
11/14/2022	Healthcare of Ontario Pension Plan Trust Fund	126,845	$8.45M	0.0%	+57.2%	0.057%
11/14/2022	Aviva PLC	390,887	$26.05M	0.2%	+17.8%	0.176%
11/14/2022	Itau Unibanco Holding S.A.	761	$51K	0.0%	N/A	0.000%
11/14/2022	FORA Capital LLC	6,400	$0.43M	0.1%	-3.2%	0.003%
11/14/2022	Royal London Asset Management Ltd.	60,369	$4.02M	0.0%	-7.0%	0.027%
11/14/2022	MetLife Investment Management LLC	55,503	$3.70M	0.0%	-2.7%	0.025%
11/14/2022	Metropolitan Life Insurance Co NY	10,822	$0.72M	0.0%	-3.1%	0.005%
11/14/2022	Shell Asset Management Co.	9,322	$0.62M	0.0%	-22.7%	0.004%
11/14/2022	Altshuler Shaham Ltd	843	$56K	0.0%	-13.9%	0.000%
11/14/2022	AustralianSuper Pty Ltd	407,269	$27.14M	0.2%	-15.9%	0.183%
11/14/2022	Hsbc Holdings PLC	618,433	$41.38M	0.1%	+60.6%	0.278%
11/14/2022	Prudential PLC	34,461	$2.30M	0.0%	+1.7%	0.015%
11/14/2022	E Fund Management Co. Ltd.	8,770	$0.58M	0.1%	+9.8%	0.004%
11/14/2022	Pictet Asset Management SA	732,855	$48.84M	0.1%	-30.2%	0.329%
11/14/2022	ING Groep NV	28,935	$1.93M	0.0%	-18.3%	0.013%
11/14/2022	Skandinaviska Enskilda Banken AB publ	338,093	$22.53M	0.2%	-14.3%	0.152%
11/10/2022	Envestnet Asset Management Inc.	17,981	$1.20M	0.0%	+38.3%	0.008%
11/10/2022	Ontario Teachers Pension Plan Board	14,406	$0.96M	0.0%	+55.7%	0.006%
11/10/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	18,438	$1.23M	0.0%	-15.1%	0.008%
11/10/2022	Intech Investment Management LLC	102,379	$6.82M	0.1%	+902.1%	0.046%
11/10/2022	Credit Suisse AG	493,467	$32.88M	0.0%	-41.5%	0.222%
11/10/2022	Nomura Asset Management Co. Ltd.	180,753	$12.05M	0.1%	-1.0%	0.081%

Data available starting January 2016

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor to treat chronic myeloid leukemia and philadelphia-chromosome positive acute lymphoblastic leukemia. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD); itacitinib, which is in Phase II/III clinical trial to treat naïve chronic GVHD; and pemigatinib for treating bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and tumor agnostic. In addition, the company engages in developing Parsaclisib, which is in Phase II clinical trial for follicular lymphoma, marginal zone lymphoma, and mantel cell lymphoma. Additionally, it develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer, as well as in Phase II clinical trials for patients with non-small cell lung cancer. It has collaboration agreements with Novartis International Pharmaceutical Ltd.; Eli Lilly and Company; Agenus Inc.; Calithera Biosciences, Inc; MacroGenics, Inc.; Merus N.V.; Syros Pharmaceuticals, Inc.; Innovent Biologics, Inc.; Zai Lab Limited; Cellenkos, Inc.; and Nimble Therapeutics, as well as clinical collaborations with MorphoSys AG and Xencor, Inc. to investigate the combination of tafasitamab, plamotamab, and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma, and relapsed or refractory follicular lymphoma. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware.

Today's Range

Now: $78.26

$77.27

$78.26

50 Day Range

MA: $72.17

$66.18

$78.41

52 Week Range

Now: $78.26

$63.40

$84.86

Volume

238,797 shs

Average Volume

1,452,921 shs

Market Capitalization

$17.41 billion

P/E Ratio

19.91

Dividend Yield

N/A

Beta

0.7

Who are the company insiders with the largest holdings of Incyte?: Incyte's top insider shareholders include:
Yao Wenqing (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Thomas Tray (Insider)
Bros Advisors Lp Baker (Director)
Dashyant Dhanak (EVP)
Herve Hoppenot (President)
Jonathan Elliott Dickinson (EVP)
Michael James Morrissey (EVP)
Paula J Swain (EVP)
Wendy L Dixon (Director)
Learn More about top insider investors at Incyte.
Who are the major institutional investors of Incyte?: Incyte's top institutional investors include:
Vanguard Group Inc. — 9.54%
BlackRock Inc. — 8.83%
State Street Corp — 4.29%
Royal Bank of Canada — 4.14%
Renaissance Technologies LLC — 2.18%
Bellevue Group AG — 1.23%
Learn More about top institutional investors of Incyte stock.
Which institutional investors are selling Incyte stock?: During the previous quarter, INCY stock was sold by these institutional investors:
First Trust Advisors LP
Price T Rowe Associates Inc. MD
Credit Suisse AG
Two Sigma Investments LP
Pictet Asset Management SA
Renaissance Technologies LLC
UBS Asset Management Americas Inc.
ARK Investment Management LLC
In the last year, company insiders that have sold Incyte company stock include:
Yao Wenqing (EVP)
Barry P Flannelly (EVP)
Vijay K Iyengar (EVP)
Thomas Tray (Insider)
Bros Advisors Lp Baker (Director)
Dashyant Dhanak (EVP)
Learn More investors selling Incyte stock.
Which institutional investors are buying Incyte stock?: Within the previous quarter, INCY stock was purchased by institutional investors including:
Barclays PLC
LSV Asset Management
BlackRock Inc.
Allspring Global Investments Holdings LLC
Armistice Capital LLC
PGGM Investments
Russell Investments Group Ltd.
Robeco Institutional Asset Management B.V.
Within the previous year, these company insiders have bought Incyte stock:
Yao Wenqing (EVP)
Barry P Flannelly (EVP)
Learn More investors buying Incyte stock.

See how to make money instead of spending it on Black Friday with this offer

From Legacy Research | Ad

Get Nomi’s latest stock market prediction for $19

INCY Insider Trading

Incyte Insider Trading History Chart

Incyte Share Price & Price History

Incyte Insider Trading History

SEC Filings (Institutional Ownership Changes) for Incyte (NASDAQ:INCY)

Institutional Buying and Selling by Quarter

Incyte Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Incyte?

Who are the major institutional investors of Incyte?

Which institutional investors are selling Incyte stock?

Which institutional investors are buying Incyte stock?